These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1099 related articles for article (PubMed ID: 18640809)

  • 1. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
    Bulte CS; van der Heiden-van der Loo M; Hennipman A
    Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
    Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
    Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study.
    Bergkvist L; de Boniface J; Jönsson PE; Ingvar C; Liljegren G; Frisell J;
    Ann Surg; 2008 Jan; 247(1):150-6. PubMed ID: 18156935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Critical study of our initial experience of 993 sentinel node biopsies for breast surgery].
    Martel P; Capdet J; Méry E; Zerdoud S; Ferron G; Rafii A; Roché H; Querleu D
    Bull Cancer; 2008; 95(7):763-72. PubMed ID: 18755653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
    J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection.
    Roumen RM; Kuijt GP; Liem IH; van Beek MW
    Br J Surg; 2001 Dec; 88(12):1639-43. PubMed ID: 11736979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
    J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
    Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
    Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Negative sentinel node in breast cancer patients a good indicator for continued absence of axillary metastases].
    Meijer S; Torrenga H; van der Sijp JR
    Ned Tijdschr Geneeskd; 2002 May; 146(20):942-6. PubMed ID: 12051063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration.
    van der Ploeg IM; Kroon BB; Antonini N; Valdés Olmos RA; Rutgers EJ; Nieweg OE
    Ann Surg Oncol; 2008 Apr; 15(4):1025-31. PubMed ID: 18219534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node.
    Snoj M; Bracko M; Zagar I
    Croat Med J; 2005 Jun; 46(3):377-81. PubMed ID: 15861515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary recurrence after negative sentinel lymph node biopsy: frequency and factors influencing recurrence on the long term.
    Sanli I; Lemaire BM; Muller AJ; van Kleffens HJ; Van Poll-Franse LV; van Dijk M
    Breast J; 2009; 15(3):236-41. PubMed ID: 19645777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
    Domènech A; Benitez A; Bajén MT; Pla MJ; Gil M; Martín-Comín J
    Oncology; 2007; 72(1-2):27-32. PubMed ID: 17998787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
    Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of sentinel lymph-node biopsy (SLNB) in the treatment of breast cancer.
    Marrazzo A; Taormina P; David M; Casà L; Lo Gerfo D; Noto A; Riili I; Ficola U; Russo L
    Chir Ital; 2006; 58(3):299-304. PubMed ID: 16845865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.